PROASSURANCE CORP. overview

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company. Under the terms of the proposed transaction, shareholders of ProAssurance will receive $25.00 in cash for each share of ProAssurance that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration...

Shareholder Alert: The Ademi Firm investigates whether ProAssurance Corporation is obtaining a Fair Price for its Public Shareholders PR Newswire MILWAUKEE, March 19, 2025 MILWAUKEE , March 19, 2025 /PRNewswire/ -- The Ademi Firm is investigating ProAssurance (NYSE: PRA) for possible breaches of fiduciary duty and other violations of law in its transaction with The Doctors Company . Click here to learn how to join our investigation and obtain additional information or contact us at...

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of ProAssurance Corporation - PRA PR Newswire NEW YORK, March 19, 2025 NEW YORK , March 19, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating ProAssurance Corporation...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of ProAssurance Corporation (NYSE: PRA) to The Doctors Company for $25.00 in cash per share is fair to ProAssurance shareholders. Halper Sadeh encourages ProAssurance shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected] . The investigation concerns whether ProAssurance and its...

The Ademi Firm is investigating ProAssurance (NYSE: PRA) for possible breaches of fiduciary duty and other violations of law in its transaction with The Doctors Company . Click here to learn how to join our investigation and obtain additional information or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, ProAssurance shareholders will receive only $25.00 in cash per share of ProAssurance common stock, with a transaction...

The Doctors Company , the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA) , an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, today announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company. Under the terms of the agreement, ProAssurance...

ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability and a core small-cap value equity in the financials sector, today reported net income of $16.2 million, or $0.31 per diluted share, and operating income (1) of $18.3 million, or $0.36 per diluted share, for the three months ended December 31, 2024. For full-year 2024, ProAssurance reported net income of $52.7 million, or $1.03 per diluted share, and operating...

ProAssurance Corporation (NYSE: PRA) will issue its news release and file its Form 10-K after the market closes on Monday, February 24, 2025. The release and 10-K will be available on the Company’s website at investor.proassurance.com . ProAssurance will conduct its Fourth-Quarter and Full-Year 2024 quarterly conference call with analysts and investors to discuss the results and other information on Tuesday, February 25, 2025, at 10:00 a.m. ET. Preregistration for the call is available here...